Global and United States Dimenhydrinate Market Report & Forecast 2022-2028

Dimenhydrinate, also known as Dramamine or Gravol, is an over-the-counter drug used to prevent nausea, vomiting, and dizziness caused by motion sickness.
Market Analysis and Insights: Global and United States Dimenhydrinate Market
This report focuses on global and United States Dimenhydrinate market, also covers the segmentation data of other regions in regional level and county level.
Due to the COVID-19 pandemic, the global Dimenhydrinate market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, by Type, Oral accounting for % of the Dimenhydrinate global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While by Application, Hospital was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.
In United States the Dimenhydrinate market size is expected to grow from US$ million in 2021 to US$ million by 2028, at a CAGR of % during the forecast period.
Global Dimenhydrinate Scope and Market Size
Dimenhydrinate market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Dimenhydrinate market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the Dimenhydrinate market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Segment by Type
Oral
Injection
Segment by Application
Hospital
Drug Store
On-line
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Bristol-Myers Squibb
Baxter Healthcare
Watson Laboratories
Pfizer
Nexgen Pharma
Goodwill Pharma
Hennig Arzneimittel
Zambon
Apotex
Teva
Mylan
Cinfa
Neuraxpharm Arzneimittel
Gedeon Richter
Medrock Biotech
Strides Pharma
Fresenius
Novartis
Johnson and Johnson
Yoshindo
IFET
Bayer
Nidda Healthcare
Medifarma